Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial ...

WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. To highlight the FDA ...

Nucleome Therapeutics CTO Jonny Wray reveals how an engineer’s mindset can help navigate the complexity of human biology ...

New Shanghai manufacturing base and innovation center will support CAR-T production and a broader UK-China life sciences collaboration AstraZeneca is the first major global biopharma to establish ...

WashU Medicine-developed WU-CART-007 has received Breakthrough Therapy designation after early clinical results in relapsed or refractory T-cell leukemias and lymphomas. This content is an ...

An off-the-shelf CAR-T cell therapy developed by researchers at WashU Medicine has been granted FDA Breakthrough Therapy designation for relapsed or refractory T-cell acute lymphoblastic leukemia and ...

The biopharmaceutical industry currently finds itself at a precarious intersection of unprecedented innovation and antiquated validation. We have unlocked unprecedented capabilities in gene editing ...

We are all watching the rise of oral, small molecule GLP-1 receptor agonists with justified interest. The promising phase III results of Eli Lilly’s orforglipron has set the pace, and others are ...

I often describe regulatory strategy as the invisible skeleton of a biotechnology company. When it is well-formed, you hardly notice it is there, yet it provides the essential structure that allows ...

Clinical development has always been a complex process, requiring various stakeholders including pharmaceutical and biotech companies, patient groups, clinical research organizations (CROs) and ...

Canavan disease is a fatal, inherited leukodystrophy that primarily affects infants and young children, and leads to severe and progressive damage to the brain’s white matter. Life expectancy is ...

“What has kept me in the industry for almost 30 years now is really that sense of passion – and the patient at the end of it. What gets me up in the morning is knowing that we’re doing things that ...